Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-18-022602

Options or other derivatives

  • Director acquired 27,297 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2018-03-12 Grant or award · Stock Option (Right to Buy) +27,297 27,297 D: show line 1 in the form
Loading xslF345X03/a4.xml…